Bank of America’s recent stance on semiconductor stocks

A Bank of America Merrill Lynch (BAC) research team recently shared its ideas on semiconductor stocks and its optimism for their future performances.

Why Bank of America Is Optimistic on Semiconductor Stocks

Analyst Vivek Arya wrote in the report, “We continue to be positive on the ‘golden age’ for semis, where cyclical reflation, secular drivers and discipline will drive earnings growth and attract new investors.”

Cyclical reflation

Cyclical reflation is a process in which policymakers try to stimulate the economy by introducing changes and new legislation. The current administration is focusing on expanding economic activity through proposed tax reforms and fiscal stimulus (SPY) (QQQ). If the corporate and individual tax rates are reduced, it could stimulate economic growth.

Secular drivers

Secular drivers aren’t cyclical but generally exist for a long period of time. They can include changes in demographics, which can be an important driver for global markets (ACWI) (VTI), and demand for technology (XLK).

According to Bank of America Merrill Lynch, all these factors could drive the earnings of semiconductor stocks and provide opportunities for investors.

In the next part of this series, we’ll look at Bank of America Merrill Lynch’s view on Broadcom (AVGO).

Latest articles

Apple (AAPL) investors have had a roller coaster week. Apple stock has lost just under 2% in a week, ending on August 23, 2019.

Competition taking a toll on Netflix as its share of US subscription video streaming market keep falling as rivals gain ground.

Crude oil production continues to rise, and oil prices remain at $50. Despite that, US energy stocks aren’t getting investors’ interest.

Apple stock fell 4.6% as the US-China trade war intensified today. China warned of tariffs on more US goods, followed by Trump's tweeted response.

In response to new tariffs from China and President Trump's tweets, the market tanked to session lows on Friday. The DJIA nosedived more than 600 points.

Coverage on Cresco Labs has increased from seven analysts in July to nine in August. Six analysts favor a “strong buy,” and three recommend a “buy.”